Evaluation and Management of Traveler's Diarrhea in Children

Frank Zhu1

  • 1Department of Pediatrics, Division of Pediatric Infectious Diseases, Medical College of Wisconsin Suite 450C, 999 North 92nd Street, Wauwatosa, WI 53226, USA.

Insights

Pediatric traveler's diarrhea requires specific management distinct from adult protocols. Current guidelines for adults are insufficient for children, necessitating tailored approaches for pediatric cases.

Area of Science:

  • Infectious Diseases
  • Pediatric Gastroenterology

Background:

  • Traveler's diarrhea is a prevalent travel-related illness affecting both pediatric and adult populations.
  • Established guidelines exist for adult traveler's diarrhea, but significant gaps remain for pediatric cases.
  • Pediatric pathophysiology, clinical presentations, and treatment differ from adults, making adult guidelines inapplicable.

Purpose of the Study:

  • To highlight the need for specific evaluation and management strategies for pediatric traveler's diarrhea.
  • To emphasize the limitations of applying adult traveler's diarrhea guidelines to children.
  • To underscore the importance of considering pediatric-specific factors in clinical practice.

Main Methods:

  • Literature review of existing guidelines and pediatric gastroenterology principles.
  • Analysis of differences in pathophysiology and clinical presentation between pediatric and adult traveler's diarrhea.
  • Synthesis of current evidence to inform pediatric management recommendations.

Main Results:

  • Significant gaps exist in current guidance for pediatric traveler's diarrhea.
  • Adult traveler's diarrhea guidelines are not directly transferable to children.
  • Pediatric-specific considerations are crucial for effective management.

Conclusions:

  • Tailored guidelines are essential for the evaluation and management of traveler's diarrhea in children.
  • Clinicians must recognize and address the unique aspects of pediatric traveler's diarrhea.
  • Further research is needed to develop evidence-based pediatric traveler's diarrhea protocols.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
235
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
353
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
450